BioRexis Pharmaceutical Corp.

Biopharmaceutical firm completes $30M series B financing

Published in Lab Business Week, April 11th, 2004

BioRexis Pharmaceutical Corporation announced that it has raised $30 million in a Series B private equity financing led by Prism Venture Partners of Westwood, Massachusetts, and Quaker BioVentures of Philadelphia, Pennsylvania.

The financing was oversubscribed and included new investors Johnson & Johnson Development Corporation, Gund Investment Corporation, and Anthem Capital and existing investors ProQuest Investments and Tullis-Dickerson & Company. BioRexis has raised over $38 million since its inception in July 2002.

As part of the financing, Duane Mason, cofounder and general partner of Prism Venture Partners, will join BioRexis' board of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2004-04-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry